C570240

2 trials

Sponsors

Hiromitsu Asashima, Akinari Fukuda

Conditions

Glycogen storage disease tyep 1b, neutropenia Glycogen storage disease tyep 1b, neutropeniaRheumatoid arthritis arthritis, chronic kidney disease

Phase 2

An exploratory study to evaluate the safety and kidney-protective effects of empagliflozin in people receiving methotrexate treatment for rheumatoid arthritis

Active, not recruitingJPRN-jRCTs031250382

Hiromitsu AsashimaRheumatoid arthritis arthritis, chronic kidney disease

Start: 2025-12-05Target: 40Updated: 2026-06-29

A study to evaluate the effect and safety of empagliflozin for neutropenia in glycogen storage disease type Ib

RecruitingJPRN-jRCTs031250458

Akinari FukudaGlycogen storage disease tyep 1b, neutropenia Glycogen storage disease tyep 1b, neutropenia

Start: 2025-10-27Target: 7Updated: 2026-06-29